Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-29

Clinical Trial Update: Bupropion as a Smoking Cessation Aid in Alcoholics [Phase 4]

View source ↗

Summary

This update reports a Phase 4 trial evaluating bupropion as a smoking cessation aid in individuals with alcoholism, sponsored by NIAAA, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcoholism, Smoking | Phase 4 | Status: COMPLETED